SCHEMBL25919201

SCHEMBL25919201

CSC1(c2ccc(Br)cc2)CCC1

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
LIG1 P18858 1/20 0.33
CYP2A6 P11509 1/20 0.33
TAAR1 Q96RJ0 1/20 0.33
ALDH1A1 P00352 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25919688 0.85 LIG1 (0.30) LIG1
SCHEMBL25919211 0.78 OPRM1 (0.41)
SCHEMBL24638233 0.75 ESR2 (0.54) ALDH1A1
SCHEMBL18093828 0.73 CYP2A6 (0.40) CYP2A6TAAR1ALDH1A1
SCHEMBL19110540 0.71 TAAR1 (0.43) LIG1CYP2A6TAAR1ALDH1A1
SCHEMBL25919215 0.70 CYP3A4 (0.31) ALDH1A1
SCHEMBL25918786 0.69 OPRM1 (0.44) TAAR1
SCHEMBL16823730 0.68 OPRL1 (0.50)
SCHEMBL29119961 0.67 TAAR1 (0.43) LIG1CYP2A6TAAR1ALDH1A1
SCHEMBL3244627 0.67 CYP2A6 (0.38) LIG1CYP2A6TAAR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023141432-A2 APOL1 INHIBITORS AND METHODS OF USE MAZE THERAPEUTICS, INC. (US) 2023-07-27 WO disclosed